LD-2 disclosure · 1st Quarter - Amendment
HARMONY BIOSCIENCES, LLC
via JEFFREY J. KIMBELL & ASSOCIATES, INC.
Client
- Description
- Biopharmaceutical company established to develop treatments for rare diseases
- Location
- Pennsylvania · United States of America
Registrant
- Firm
- JEFFREY J. KIMBELL & ASSOCIATES, INC.
- Description
- Consulting Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; Medicare Part D redesign; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. H.R. 2673, The American Innovation and R&D Competitiveness Act.
Lobbyistsmr JEFFREY J KIMBELL · JODIE LOCKHART · JOHN HERZOG · KEITH STUDDARD · JOHN R RAY · DAVID RUDLOFF · mr KENNETH LEE HODGE
Covered position (JOHN HERZOG): Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President
Covered position (KEITH STUDDARD): Legislative Director, Rep. Marsha Blackburn
Covered position (JOHN R RAY): Legislative Assistant, Rep. Mike Kelly
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to Medicare Part D redesign.
Lobbyistsmr JEFFREY J KIMBELL · JODIE LOCKHART · JOHN HERZOG · KEITH STUDDARD · JOHN R RAY · DAVID RUDLOFF · mr KENNETH LEE HODGE
Covered position (JOHN HERZOG): Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President